Geron Corp. (NASDAQ: GERN) Rating Reiterated at BTIG Research

Analysts at BTIG Research reiterated a Neutral rating on shares of Geron Corp. (NASDAQ: GERN) in a reserach note to investors, making it one of the more closely watched stocks on Wall Street. BTIG Research currently has a rating of Neutral on the stock. The one-year price target of $4.38 is higher than the opening price of $2.02, that has caused a number of other analysts to comment on the company in recent days. Looking back over the last year, Geron Corp. stock has a high of $5.30. Share prices often move to the upside on recommendations and new price targets of professional brokerage firms.

U.S. stocks closed higher Tuesday as investors anticipate the results of meetings from the Federal Reserve and the Bank of Japan.

The Dow Jones Industrial Average DJIA, +0.05% rose 9.79 points, or less than 0.1%, to close at 18,129.96.

The S&P 500 index SPX, +0.03% advanced 0.64 points to finish at 2,139.76, led by gains in the health-care and consumer-staples sectors.

The Nasdaq Composite index COMP, +0.12% gained 6.33 points, or 0.1%, to close at 5,241.35.

Shares of Geron Corp. (NASDAQ: GERN) opened at $2.02 yesterday and traded in a range between, $2.01 and $2.12, and last traded at $2.05, which represents a spike of $0.05 over the previous closing price.

Geron Corp. (NASDAQ: GERN) currently has a market cap of 326.23M.

2,887,882 shares traded hands yesterday, 75 percent higher than the average, out of a total float 158,349,000. Heavy volume aggregation by institutional investors may be in the near future as the combination of significant increases in trading volume and price appreciation can be determining components.

However, just a day of high volume buy side trading is not enough to determine a trend. As such, market traders will continue to look for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts researching thousands of stocks, so it is good corroboration to see them taking a postion in a stock you’re considering.

By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

With that in mind, Geron Corp. (NASDAQ: GERN) now has a 50-day MA of $2.62 and 200-day MA of $2.79. It has traded in a 52-week range between $1.84 – 5.30 and today’s last price is 0.61% lower than the 52 week high of $5.30.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors identify companies that have been successful at growing their earnings by at least 25% over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.